Human Longevity - About the company
Human Longevity is a series B company based in San Diego (United States), founded in 2013 by Peter H Diamandis and J Craig Venter. It operates as a Provider of precision medicine, preventative health assessments, and longevity care. Human Longevity has raised $409M in funding from investors like General Electric, Celgene and Emerging Technology Partners, with a current valuation of $310M. The company has 541 active competitors, including 93 funded and 79 that have exited. Its top competitors include companies like Denali Therapeutics, Caris Life Sciences and MedGenome.
Sectors and market segments that Human Longevity operate in
Human Longevity serves in the Life Sciences, HealthTech market segments.The primary business model of Human Longevity are:Company Details
Provider of precision medicine, preventative health assessments, and longevity care. The company offers comprehensive health assessments to detect life-threatening conditions early. It focuses on data-driven, personalized healthcare designed to uncover health risks. The company provides services to help individuals take control of their health.
- Website
- www.humanlongevity.com/
- Social
- Email ID
- *****@humanlongevity.com
- Phone Number
- +1 **********
- Registered Address
- San Diego, California
Key Metrics
Founded Year
2013
Location
San Diego, United States
Stage
Series B
Total Funding
$409M in 6 rounds
Latest Funding Round
Post Money Valuation
$310M as on Dec 10, 2018
Investors
Ranked
1st among 541 active competitors
Employee Count
79 as on Apr 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Human Longevity
Human Longevity is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Human Longevity, Inc. CIN: 463131906 , United States, Active | Dec 26, 999 | - | 83 (As on Dec 31, 2019) | - |
Human Longevity, Inc. CIN: 20151252151 , United States, Active | Apr 13, 2015 | - | - | - |
Sign up to download Human Longevity's company profile
Human Longevity's funding and investors
Human Longevity has raised a total funding of $409M over 6 rounds. Its first funding round was on Mar 04, 2014. Its latest funding round was a Series B round on Aug 21, 2024 for $39.8M. 3 investors participated in its latest round. Human Longevity has 21 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Human Longevity:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 21, 2024 | $39.8M | Series B | - | - | ||
Mar 13, 2023 | $32M | Series B | - | - | - | - |
Oct 11, 2022 | $6.92M | Series B | - | - | - | - |
Access funding benchmarks and valuations. Sign up today!View details of Human Longevity's funding rounds and investors
Human Longevity's founders and board of directors
Founder? Claim ProfileThe founders of Human Longevity are Peter H Diamandis and J Craig Venter. J Craig Venter is the CEO of Human Longevity.
Here are the details of Human Longevity's key team members:
- Peter H Diamandis: Co-Founder of Human Longevity and founder of 10 other companies, including Nokia Sensing XCHALLENGE, SingularityHub and Bold Capital Partners. They are also an angel investor in 6 startups.
- J Craig Venter: Co-Founder & CEO of Human Longevity.
View details of Human Longevity's Founder profiles and Board Members
Human Longevity's employee count trend
Human Longevity has 79 employees as of Apr 26. Here is Human Longevity's employee count trend over the years:
Uncover Human Longevity's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Human Longevity's Competitors and alternates
Top competitors of Human Longevity include Denali Therapeutics, Caris Life Sciences and MedGenome. Here is the list of Top 10 competitors of Human Longevity, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Human Longevity 2013, San Diego (United States), Series B | Provider of precision medicine, preventative health assessments, and longevity care | $409M | 76/100 | |
2nd | Denali Therapeutics 2015, San Francisco (United States), Public | Developer of therapies to treat neurodegenerative diseases | $347M | 72/100 | |
3rd | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 71/100 | |
4th | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 71/100 | ||
5th |  Premise 2012, San Francisco (United States), Series E | Crowdsourced real-time offline economic data tracking | $152M | 71/100 | |
6th |  Enigma 2011, New York City (United States), Series C | Provider of business data and intelligence for risk and growth management | $130M | 71/100 | |
7th | Market research platform | $26.4M | 70/100 | ||
8th | YipitData 2010, New York City (United States), Series E | Provider of data and analysis on company performance and consumer behavior | $492M | 69/100 | |
9th |  Data Sutram 2018, Mumbai (India), Series A | Provider of external intelligence for financial decisions across customer lifecycle | $15M | 65/100 | |
10th | _1582012509394.png?devicePixelRatio=2&height=30&width=30){kind=logo} ACT Genomics 2014, Taipei (Taiwan), Acquired | Clinical and research services in genomics for cancer | $20.5M | 64/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Human Longevity's competitors? Click here to see the top ones
Human Longevity's Investments and acquisitions
Human Longevity has made 9 investments in companies including AMI Cardiac Monitoring and HUMA.AI. Human Longevity has also acquired 3 companies including DoctorsForMe.AI and LifebankUSA.Here is the list of investments & acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
2024 | Investments | 1991 | Rockville (United States) | |
Feb 03, 2022 | Investments | 2018 | Palo Alto (United States) | |
Apr 22, 2021 | Investments | 2018 | San Mateo (United States) |
_1535689687483.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by Human Longevity
Reports related to Human Longevity
Here is the latest report on Human Longevity's sector:
News related to Human Longevity
Filter this listMedia has covered Human Longevity for a total of 5 events in the last 1 year, 3 of them have been about company updates and 2 about partnerships.
•
•
•
•
Human Longevity, Inc. Expands $1 Million Cancer Prevention Pledge for Ovarian CancerPR Newswire•Jul 18, 2025•Human Longevity
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Human Longevity
Explore our recently published companies
- Carer - Bengaluru based, 2020 founded, Unfunded company
- Petsessentia - 2023 founded, Unfunded company
- Relaxora - India based, Unfunded company
- Wallkalakar - Delhi based, 2012 founded, Unfunded company
- Excitigo Excursions - Gurugram based, 2017 founded, Unfunded company
- Doctordoorstep.com - Unfunded company
